Qunli Xu

2.2k total citations
27 papers, 1.8k citations indexed

About

Qunli Xu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Qunli Xu has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Qunli Xu's work include Fungal and yeast genetics research (5 papers), Cancer-related Molecular Pathways (4 papers) and Cell Adhesion Molecules Research (4 papers). Qunli Xu is often cited by papers focused on Fungal and yeast genetics research (5 papers), Cancer-related Molecular Pathways (4 papers) and Cell Adhesion Molecules Research (4 papers). Qunli Xu collaborates with scholars based in United States, Canada and Japan. Qunli Xu's co-authors include John C. Reed, Shigemi Matsuyama, John C. Reed, Jean Velours, Gerald C. Johnston, Richard A. Singer, Irina M. Shapiro, Jonathan A. Pachter, David T. Weaver and Vihren N. Kolev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Qunli Xu

25 papers receiving 1.8k citations

Peers

Countries citing papers authored by Qunli Xu

Since Specialization

Citations

This map shows the geographic impact of Qunli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunli Xu more than expected).

Fields of papers citing papers by Qunli Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunli Xu. The network helps show where Qunli Xu may publish in the future.

Co-authorship network of co-authors of Qunli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qunli Xu. A scholar is included among the top collaborators of Qunli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunli Xu. Qunli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer 2023 ·Targeted Oncology ·Maureen Caligiuri, (unknown), (unknown), (unknown), Erik Wilker, Lili Yao, (unknown), Angela V. Toms, Ping Li, Eneida Pardo, Bradford Graves, (unknown), Agustin Chicas, Torsten Herbertz, Maria Eliana Lai, (unknown), Kenneth W. Wood, Qunli Xu, Sylvie M. Guichard	20
2	Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity 2016 ·International Journal of Cancer ·Esther A. Guzmán, Qunli Xu, Tara P. Pitts, Kaoru Mitsuhashi, Cheryl H. Baker, (unknown), Judy Oestreicher, Karen TenDyke, (unknown), Edward M. Suh, Amy E. Wright	25
3	PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells 2014 ·Cancer Research ·Vihren N. Kolev, Quentin G. Wright, Christian M. Vidal, Jennifer E. Ring, Irina M. Shapiro, Jill M. Ricono, David T. Weaver, Mahesh V. Padval, Jonathan A. Pachter, Qunli Xu	116
4	VS-4718, a Potent Focal Adhesion Kinase (FAK) Inhibitor, Exhibits Anticancer Activity in Leukemia Models in Vitro and in Vivo 2014 ·Blood ·Winnie F. Tam, Jennifer E. Ring, Anthony F. Trombino, David T. Weaver, Jonathan A. Pachter, Mahesh V. Padval, Qunli Xu	2
5	Synthesis and Properties of an Aza-coumarin Based Sensor for Detection of Zn²⁺, Cd²⁺and Cu²⁺ 2014 ·Chinese Journal of Organic Chemistry ·Jiangli Fan, Qunli Xu, (unknown), Xiaojun Peng	1
6	Abstract C271: FAK inhibitor defactinib (VS-6063) enhances the efficacy of paclitaxel and preferentially targets ovarian cancer stem cells. 2013 ·Molecular Cancer Therapeutics ·Christian M. Vidal, Vihren N. Kolev, Quentin G. Wright, Winnie F. Tam, David T. Weaver, Mahesh V. Padval, Qunli Xu, Jonathan A. Pachter	2
7	Focal adhesion kinase (FAK) inhibitors VS-6063 and VS-4718 target cancer stem cells. 2013 ·Journal of Clinical Oncology ·Qunli Xu, Vihren N. Kolev, Quentin G. Wright, Irina M. Shapiro, Christian M. Vidal, Mahesh V. Padval, Mitchell Keegan, (unknown), (unknown), Jonathan A. Pachter	2
8	Abstract LB-194: The Wnt inhibitor VS-507 reduces cancer stem cell (CSC) function in vitro and tumorigenicity in mice 2012 ·Cancer Research ·Jonathan A. Pachter, Jennifer E. Ring, (unknown), Christian M. Vidal, Brian Sullivan, Kevin T. Sprott, Mahesh V. Padval, Qunli Xu	1
9	In vitro and in vivo anticancer activity of (+)-spongistatin 1. 2011 ·PubMed ·Qunli Xu, Kuan‐Chun Huang, Karen TenDyke, Joanne Marsh, Junke Liu, Dayong Qiu, Bruce A. Littlefield, K. Nomoto, Onur Atasoylu, (unknown), Jeffrey B. Sperry, Amos B. Smith	17
10	Design, Synthesis, and Biological Evaluation of Diminutive Forms of (+)-Spongistatin 1: Lessons Learned 2011 ·Journal of the American Chemical Society ·Amos B. Smith, (unknown), Onur Atasoylu, Clay S. Bennett, Junke Liu, Hongsheng Cheng, Karen TenDyke, Qunli Xu	24
11	Design, Synthesis, and Biological Evaluation of EF- and ABEF- Analogues of (+)-Spongistatin 1 2010 ·Organic Letters ·Amos B. Smith, (unknown), Onur Atasoylu, Clay S. Bennett, Karen TenDyke, Qunli Xu	12
12	Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A 2009 ·Molecular Cancer Therapeutics ·Galina Kuznetsov, Qunli Xu, (unknown), Karen TenDyke, Junke Liu, Murray J. Towle, Nanding Zhao, Joanne Marsh, Sergei Agoulnik, Natalie C. Twine, Lana Parent, Zhihong Chen, Jue‐Lon Shie, Yimin Jiang, Huiming Zhang, Hong Du, Roch P. Boivin, Yuan Wang, Daniel Romo, Bruce A. Littlefield	85
13	Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis 2004 ·Journal of Biological Chemistry ·Thelma Thompson, Christian Tovar, Hong Yang, Daisy Carvajal, Binh Thanh Vu, Qunli Xu, Geoffrey M. Wahl, David Heimbrook, Lyubomir T. Vassilev	198
14	Assays for Studying Bax-Induced Lethality in the Yeast Saccharomyces cereνisiae 2000 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Qunli Xu, Ke Ning, Shigemi Matsuyama, John C. Reed	11
15	BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins 2000 ·Proceedings of the National Academy of Sciences ·Hong Zhang, Qunli Xu, Stanisław Krajewski, Maryla Krajewska, Zhihua Xie, Sally Fuess, Shinichi Kitada, Krzysztof Pawłowski, Adam Godzik, John C. Reed	151
16	Methods of Assaying Bcl-2 and Bax Family Proteins in Yeast 1999 ·Methods ·Qunli Xu, Juliane M. Jürgensmeier, John C. Reed	18
17	Bax Inhibitor-1, a Mammalian Apoptosis Suppressor Identified by Functional Screening in Yeast 1998 ·Molecular Cell ·Qunli Xu, John C. Reed	438
18	The Mitochondrial F0F1-ATPase Proton Pump Is Required for Function of the Proapoptotic Protein Bax in Yeast and Mammalian Cells 1998 ·Molecular Cell ·Shigemi Matsuyama, Qunli Xu, Jean Velours, John C. Reed	244
19	Sug1 Modulates Yeast Transcription Activation by Cdc68 1995 ·Molecular and Cellular Biology ·Qunli Xu, Richard A. Singer, Gerald C. Johnston	50
20	The Saccharomyces cerevisiae Cdc68 Transcription Activator Is Antagonized by San1, a Protein Implicated in Transcriptional Silencing 1993 ·Molecular and Cellular Biology ·Qunli Xu, Gerald C. Johnston, Richard A. Singer	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact